Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Knuth

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Structure-activity profiles of Ab-derived TNF fusion proteinsStefan Bauer, Nicole Adrian, Eliane Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patientsNatko Nuber, Alessandra Curioni-Fontecedro, Claudia Matter, et al.
BMC Cancer|January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II studyAlexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Oncology|April 29, 2006
Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancerSalah-Eddin Al-Batran, Hans-Gerd Meerpohl, Gunter von Minckwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancerSalah-Eddin Al-Batran, Akin Atmaca, Susanna Hegewisch-Becker, et al.
Cancer Immunity|May 16, 2003
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51Elke Jäger, Julia Karbach, Sacha Gnjatic, et al.
Plos One|July 12, 2013
RP1 is a phosphorylation target of CK2 and is involved in cell adhesionFrank Stenner, Heike Liewen, Stephan Göttig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastasesZsuzsanna Varga, Jean-Philippe Theurillat, Valeriy Filonenko, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2011
Immunosuppression and lung cancer of donor origin after bilateral lung transplantationLotta von Boehmer, Alice Draenert, Wolfgang Jungraithmayr, et al.
Vaccines|March 6, 2020
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes MellitusElisa S Roesti, Christina N Boyle, Daniel T Zeman, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Structure-activity profiles of Ab-derived TNF fusion proteinsStefan Bauer, Nicole Adrian, Eliane Fischer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Fine analysis of spontaneous MAGE-C1/CT7-specific immunity in melanoma patientsNatko Nuber, Alessandra Curioni-Fontecedro, Claudia Matter, et al.
BMC Cancer|January 13, 2018
Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II studyAlexander R Siebenhüner, Heike Seifert, Helga Bachmann, et al.
Oncology|April 29, 2006
Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancerSalah-Eddin Al-Batran, Hans-Gerd Meerpohl, Gunter von Minckwitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancerSalah-Eddin Al-Batran, Akin Atmaca, Susanna Hegewisch-Becker, et al.
Cancer Immunity|May 16, 2003
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51Elke Jäger, Julia Karbach, Sacha Gnjatic, et al.
Plos One|July 12, 2013
RP1 is a phosphorylation target of CK2 and is involved in cell adhesionFrank Stenner, Heike Liewen, Stephan Göttig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastasesZsuzsanna Varga, Jean-Philippe Theurillat, Valeriy Filonenko, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2011
Immunosuppression and lung cancer of donor origin after bilateral lung transplantationLotta von Boehmer, Alice Draenert, Wolfgang Jungraithmayr, et al.
Vaccines|March 6, 2020
Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes MellitusElisa S Roesti, Christina N Boyle, Daniel T Zeman, et al.
Pageof 13